JBAEM
Clinical Laboratory Science Communicable Diseases Critical Care Diabetes Emergency Medicine Endocrinology Epidemiology Gastroenterology & Hepatology Neurology Cardiology
? Call for Papers — Journal of Best Available Evidence in Medicine (JBAEM)
JBAEM is a peer-reviewed journal dedicated to advancing evidence-based clinical practice by publishing high-quality research across all medical specialties. We prioritize methodological rigor and clinical relevance, evaluating manuscripts based on the strength of the evidence they provide rather than novelty alone.
We welcome the following article types:
✅ Original research
✅ Clinical epidemiology and outcomes research
✅ Systematic reviews and meta-analyses
✅ AI in clinical practice
✅ Diagnostic and prognostic accuracy studies
✅ Case reports and case series with significant evidence-based educational value
✅ Clinical practice guideline commentary
✅ Evidence-based narrative reviews
✅ Questionnaire validation studies
✅ Letters to the Editor
Why publish with JBAEM:
✨ NO article processing charges (APCs)
✨ Fully open access under the Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0) License
✨ Initial editorial decision within 2–4 weeks
✨ Double-blind peer review
✨ Crossref DOI assigned to every published article
✨ Indexed in Google Scholar and WHO Index Medicus for the Eastern Mediterranean Region (IMEMR)
✨ MEDLINE indexing application planned for December 2026
✨ Enhanced visibility through Geneva Foundation for Medical Education and Research (GFMER), Semantic Scholar, ResearchGate, and ROAD
✨ Our AI-assisted submission system makes the process faster and easier.
? Submission deadline for the upcoming issue: November 1st, 2026
Please read the Author Guidelines before submitting your manuscript.
? Submit your manuscript:
https://jbaem.opensciencepress.com/manuscript-submission
Editor-in-Chief: Reida El Oakley, MBBS, FRCS, MD
Published by Open Science Press, London, UK.
Affiliated to: Libyan International University.
We welcome your submission and encourage you to share this announcement with colleagues whose work aligns with our scope.